CERo Therapeutics Holdings, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|
Revenue | $0 | $1,162 | $0 |
Gross Profit | -269 | -297 | |
EBITDA | -5,163 | -4,837 | -4,402 |
EBIT | -5,431 | -5,106 | |
Net Income | -5,417 | -5,105 | -4,227 |
Net Change In Cash | 0 | 1,162 | 0 |
Free Cash Flow | -4,623 | -4,445 | -1,318 |
Cash | 3,302 | 5,203 | 3,380 |
Basic Shares | 488 | 1,713 | 248 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -1,117 | ||
EBITDA | -2,441 | -68 | -332 |
EBIT | -2,444 | -2,974 | -1,067 |
Net Income | -2 | -667 | -315 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -5,789 | -1,786 | -1,309 |
Cash | 1,601 | 42,141 | 1,098 |
Basic Shares | 2 | 33 | 114 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$61.71 |
2025-03-31 | -$31.80 |
2024-12-31 | -$17.49 |
2024-09-30 | -$170.22 |
